Reference Pricing 1 November 2016
The following products are being reference priced from 1 November 2016, which comes about from an alternative being award the Sole Supply within the next few months.
With price support from the suppliers ProPharma / PWR will be reducing the pricing to match the new subsidy from 13 October 2016.
We are highlighting these so that you have time to manage the transition.
Pharmacode 2133024 Solian Tab 100 mg 30 from $6.22 to $4.56 and to be delisted 1 February 2017
Pharmacode 2133032 Solian Tab 200 mg 30 from $21.92 to $14.75 and to be delisted 1 February 2017
Pharmacode 2133040 Solian Tab 400 mg 30 from $44.52 to $27.70 and to be delisted 1 February 2017
Naturally where practical and possible we would appreciate your continuing to order the incumbent brand as long as possible so that we can clear the supply chain. It helps both you and us. Margin is marginally better on the incumbent product.
ProPharma / PWR will put an automatic replacement on where practical so that once the supply chain has exhausted, you will be supplied with the alternative.
No price support provided for Ceftriaxone-AFT Injection 0.5 g & 1 g therefore price will not be reduced until stocks in the supply chain currently are depleted. We will replace automatically to new brand at that time.
Price Increase and Patient surcharge will apply to all strengths of Zarator Tablets.